Preview

Медицинский Совет

Расширенный поиск

Кишечная микробиота: современные доказательные данные эффективности применения Lactobacillus rhamnosus GG и Bifidobacterium longum в практике педиатра

https://doi.org/10.21518/2079-701X-2018-11-175-180

Полный текст:

Аннотация

В статье представлены современные данные о составе, становлении и роли кишечной микробиоты. Показана взаимосвязь между изменениями микробиоты кишечника и формированием различных форм патологии. Приведены данные об эффективности профилактического и лечебного действия пробиотических штаммов, наиболее часто используемых в практике педиатра.

 

Об авторах

А. В. Горелов
ФБУН «Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора», Москва; ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)
Россия
профессор, чл.-корр. РАН


Е. В. Каннер
ФБУН «Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора», Москва
Россия
к.м.н.


М. Л. Максимов
Казанская государственная медицинская академия – филиал ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России
Россия
д.м.н.


А. С. Ермолаева
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)
Россия
к.м.н.


А. А. Вознесенская
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский университет)
Россия


К. Н. Дадашева
ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского»
Россия


Список литературы

1. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell, 2012, 148(6): 1258–1270. doi: 10.1016/j.cell.2012.01.035.

2. Cabreiro F, Gems D. Worms need microbes too: microbiota, health and aging in Caenorhabditis elegans. EMBO Mol Med, 2013, 5(9): 1300–1310. doi: 10.1002/emmm.201100972.

3. Hill C, Guarner F, Reid G, et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol, 2014, 11(8): 506–514. doi: 10.1038/nrgastro.2014.66.

4. Chan YK, Estaki M, Gibson DL. Clinical consequences of dietinduced dysbiosis. Ann Nutr Metab, 2013, 63(Suppl 2): 28–40. doi: 10.1159/000354902.

5. Peris-Bondia F, Latorre A, Artacho A, et al. The active human gut microbiota differs from the total microbiota. PLoS One, 2011, 6(7): e22448. doi: 10.1371/journal.pone.0022448.

6. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol, 2011, 17(5): 557–566. doi: 10.3748/wjg.v17.i5.557.

7. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet, 2003, 361(9356): 512–519. doi: 10.1016/S0140-6736(03)12489-0.

8. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev, 2010, 90(3): 859-904, doi: 10.1152/phys-rev.00045.2009

9. Jimenez E, Marin M, Martin R, et al. Is meconi-um from healthy newborns actually sterile? Res Microbiol, 2008, 159(3): 187–193. doi: 10.1016/j.resmic.2007.12.007.

10. Hu J, Nomura Y, Bashir A, et al. Diversified microbiota of meconium is affected by maternal diabetes status. PLoS One, 2013, 8(11): e78257. doi: 10.1371/journal.pone.0078257.

11. Collado MC, Rautava S, Aakko J, et al. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep, 2016, 6: 23129. doi: 10.1038/ srep23129.

12. DiGiulio DB. Diversity of microbes in amniotic fluid. Semin Fetal Neonatal Med, 2012, 17(1): 2–11. doi: 10.1016/j.siny.2011.10.001.

13. Shiozaki A, Yoneda S, Yoneda N, et al. Intestinal microbiota is different in women with preterm birth: results from terminal restriction fragment length polymorphism analysis. PLoS One, 2014, 9(11): e111374. doi: 10.1371/journal.pone.0111374.

14. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A, 2010, 107(26): 11971–11975. doi: 10.1073/pnas.1002601107.

15. Biedermann L, Rogler G. The intestinal microbiota: its role in health and disease. Eur J Pediatr, 2015, 174(2): 151–167. doi: 10.1007/s00431-014-2476-2

16. Chu D, Ma J, Prince A, et al. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med, 2017, 23(3): 314–326. doi: 10.1038/nm.4272.

17. Fouhy F, Guinane C, Hussey S, et al. High-throughput sequen cing reveals the incomplete, short-term recovery of infant gut micro-biota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob Agents Chemother, 2012, 56(11): 5811–5820. doi: 10.1128/aac.00789-12.

18. Tanaka S, Kobayashi T, Songjinda P, et al. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol Med Microbiol, 2009, 56(1): 80–87. doi: 10.1111/j.1574-695x.2009.00553.x.

19. Fernandez L, Langa S, Martin V, et al. The human milk microbiota: origin and potential roles in health and disease. Pharmacol Res, 2013, 69(1): 1–10. doi: 10.1016/j.phrs.2012.09.001.

20. Backhed F, Roswall J, Peng Y, et al. Dynamics and stabilization of the human gut microbiome during the first year of life. Cell Host Microbe, 2015, 17(6): 852. doi: 10.1016/j.chom.2015.05.012.

21. Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe, 2011, 17(6): 478–482. doi: 10.1016/j.anaerobe.2011.03.009.

22. Penders J, Vink C, Driessen C, et al. Quantification of Bifidobacterium spp., Escherichia coli and Clostridium difficile in faecal samples of breastfed and formula-fed infants by real-time PCR. FEMS Microbiol Lett, 2005, 243(1): 141–147. doi: 10.1016/ j.femsle.2004.11.052.

23. Fons M, Gomez A, Karjalainen T. Mechanisms of colonization and colonization resistance of the digestive tract. Microbial Ecol Health Dis. Suppl, 2000, 2: 240–246.

24. Ardatskaya MD, Dubinin AV, Minushkin ON. Terapev-ti cheskii Arkhiv – Therapeutic Archive, 2001, 2: 67–72.

25. Yaeshima T. Benefits of bifidobacteria to human health. Bulletin of the IDF, 1996, 313: 36–42.

26. Johansson M, Sjogren Y, Persson J, et al. Early col-onization with a group of Lactobacilli decreases the risk for allergy at five years of age despite allergic heredity. PLoS One, 2011, 6(8): e23031. doi: 10.1371/journal.pone.0023031.

27. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol, 2011, 128(3): 646–652.e5. doi: 10.1016/j.jaci.2011.04.060.

28. Samuel B, Gordon J. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci USA, 2006, 103(26): 10011–10016. doi: 10.1073/pnas.0602187103.

29. Abrahamsson T, Jakobsson H, Andersson A, et al. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol, 2012, 129(2): 434–440.e2. doi: 10.1016/ j.jaci.2011.10.025.

30. Ismail I, Oppedisano F, Joseph S, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol, 2012, 23(7): 674–681. doi: 10.1111/j.1399-3038.2012.01328.x.

31. Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multi-sensitized atopy and T cell differentiation. Nat Med, 2016, 22(10): 1187–1191. doi: 10.1038/nm.4176

32. Isolauri E. Microbiota and obesity. Nestle Nutr Inst Workshop Ser, 2017, 88: 95–105. doi: 10.1159/000455217.

33. Backhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA, 2004, 101(44): 15718–15723. doi: 10.1073/ pnas.0407076101.

34. Kalliomaki M, Collado M, Salminen S, Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr, 2008, 87(3): 534–538.

35. who.int [Internet]. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. Guidelines for the evaluation of probiotics in food. London, Ontario, Canada, 2002. 11 p. [cited 2017 Jun 29]. Available from: http: //www.who.int/foodsafety/ fs_management/en/probiotic_ guidelines.pdf.

36. Huff BA. Caveat emptor. «Probiotics» might not be what they seem. Can Fam Physician, 2004, 50: 583–587.

37. Presti I, D’Orazio G, Labra M, et al. Evaluation of the probiotic properties of new Lactobacillus and Bifidobacterium strains and their in vitro effect. Appl Microbiol Biotechnol, 2015, 99(13): 5613–5626. doi: 10.1007/s00253-015-6482-8.

38. Silva M, Jacobus NV, Deneke C et al. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother, 1987, 31(8): 1231–3.

39. Gorbach SL, Goldin BR. Lactobacillus strains and methods of selection. US Patent. N 4839281.

40. Conway PL, Gorbach SL, Goldin BR. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci, 1987, 70(1): 1–12.

41. Issa I, Moucari R. Probiotics for antibiotic-associated diarrhea: Do we have a verdict? World J Gastroenterol, 2014 Dec 21, 20(47): 17788–17795.

42. Johnston BC, Supina AL, Vohra S. Probiotics for pediatric antibiotic-associated diarrhea: a meta-analysis of randomized placebo-controlled trials. CMAJ, 2006, 175(4): 377–83.

43. Kalliomaki M, Salminen S, Poussa T, Isolauri E. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a rand-omized, placebo-controlled trial. J Allergy Clin Immunol, 2007 Apr, 119(4): 1019–21.

44. Szajewska H, Skorka A, Ruszczynski M, Gieruszczak-Bialek D. Meta-analysis: Lactobacillus GG for treating acute gastroenteritis in children – updated analysis of randomised controlled trials. Aliment Pharmacol Ther, 2013, 38(5): 467–476.

45. Усенко Д.В., Плоскирева А.А., Горелов А.В. Острые кишечные инфекции у детей в практике педиатра: возможности диагностики и терапии. Вопросы современной педиатрии, 2014, 13(3): 12-20

46. Raza S, Graham SM, Allen SJ et al. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J, 1995, 14(2): 107–11.

47. Huang J, Bousvaros A, Lee J et al. Efficacy of pro-biotic use in acute diarrhea in children, a meta-analysis. Dig Dis Sci, 2002, 47(11): 2625–34.

48. Van Niel CW, Feudtner C, Garrison MM et al. Lactobacillus therapy for acute infectious diar-rhea in children: a metaanalysis. Pediatrics, 2002, 109(4): 678–84.

49. Hojsak I, Abdovic S, Szajewska H et al. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics, 2010, 125(5): е1171–7.

50. Loesche WJ. Microbiology of dental decay and periodontal disease. In: Baron’s Medical Microbiology (4th Ed). University of Texas Medical Branch, 1996.

51. Nase L, Hatakka K, Savilahti E et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res, 2001, 35(6): 412–20.

52. Turroni F, Berry D, Ventura M. Editorial: Bifido-bacteria and Their Role in the Human Gut Micro-biota. Frontiers in Microbiology, 2016, 7: 2148.

53. Bennet R, Nord CE, Zetterstrom R. Transient colonization of the gut of newborn infants by orally administered bifidobacteria and lactobacilli. Acta Ped, 1992, 81: 784–787.

54. Akiyama K, Shimada M, Ishizeki S et al. Effects of administration of Bifidobacterium in extremely premature infants: development of intestinal microflora by orally administered B. longum. Acta Neonatalogica Japonica, 1994, 30: 257–263.

55. Uhlemann M, Heine W, Mohr C et al. Effects of oral administration on intestinal microflora in premature and newborn infants. Z Geburtshife Neonatal, 1999, 203: 213–217.

56. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ, 2001, 322: 1327-9.

57. Näse L, Hatakka K, Savilahti E, Saxelin M, Ponka A, Poussa T, et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res, 2001, 35: 412-20.

58. Basu S, Chatterjee M, Ganguly S, Chandra PK. Effect of Lactobacillus rhamnosus GG in persistent diarrhea in Indian children: a randomized controlled trial. J Clin Gastroenterol, 2007a, 41: 756-60.


Просмотров: 235


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2079-701X (Print)
ISSN 2658-5790 (Online)